| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Provention Bio, Inc. | Director | Common Stock | 10,000 | $243,200 | $24.32 | 13 Apr 2023 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Director | Common Stock, par value $0.0001 per share | 4,350 | $130,500 | $30 | 30 May 2024 | Direct |
| Corbus Pharmaceuticals Holdings, Inc. | Director | Stock Option (right to buy) | 2,783 | $13,832 | $4.97 | 16 May 2024 | Direct |
| Provention Bio, Inc. | Director | Common Stock | 0 | $24.32 | 27 Apr 2023 | By the Avery Catlin Charitable Giving Fund | |
| Provention Bio, Inc. | Director | Common Stock | 0 | $24.32 | 27 Apr 2023 | By the Avery W. Catlin Revocable Trust | |
| Provention Bio, Inc. | Director | Option to Purchase Common Stock | 0 | 27 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 30 May 2024 | 1 | $0 | 4 | Director | 03 Jun 2024, 16:31 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 16 May 2024 | 1 | $0 | 4 | Director | 20 May 2024, 16:55 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 18 May 2023 | 1 | $0 | 4 | Director | 22 May 2023, 16:17 |
| PRVB | Provention Bio, Inc. | 27 Apr 2023 | 7 | $0 | 4 | Director | 27 Apr 2023, 18:02 |
| PRVB | Provention Bio, Inc. | 13 Apr 2023 | 2 | $0 | 4 | Director | 14 Apr 2023, 17:24 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 18 May 2022 | 1 | $0 | 4 | Director | 19 May 2022, 14:23 |
| PRVB | Provention Bio, Inc. | 17 May 2022 | 1 | $0 | 4 | Director | 18 May 2022, 18:04 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 17 Jun 2021 | 2 | $0 | 4 | Director | 17 Jun 2021, 16:40 |
| PRVB | Provention Bio, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 14 May 2021, 19:48 |